Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada

被引:4
|
作者
Bever, Andrea [1 ]
Salters, Kate [1 ,2 ]
Tam, Clara [1 ]
Moore, D. M. [1 ,3 ]
Sereda, Paul [1 ]
Wang, Lu [1 ]
Wesseling, Tim [1 ]
Grieve, Sean [1 ]
Bingham, Brittany [4 ]
Barrios, Rolando [1 ,3 ,5 ]
机构
[1] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada
[2] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada
[3] Univ British Columbia, Vancouver, BC, Canada
[4] Vancouver Coastal Hlth Author, Aboriginal Hlth Program, Vancouver, BC, Canada
[5] Vancouver Coastal Hlth, Vancouver Community Hlth Serv, Vancouver, BC, Canada
来源
BMJ OPEN | 2020年 / 10卷 / 05期
关键词
HIV & AIDS; British Columbia; cohort studies; antiretroviral therapy; COMMUNITY-BASED RESEARCH; HAT-QOL INSTRUMENT; ANTIRETROVIRAL THERAPY; VIRAL SUPPRESSION; HIV; SCALE; RELIABILITY; PEOPLE; CARE; QUESTIONNAIRE;
D O I
10.1136/bmjopen-2019-033649
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose The Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) Program Evaluation (SHAPE) study is a longitudinal cohort developed to monitor the progress of an HIV testing and treatment expansion programme across the province of British Columbia (BC). The study considers how sociostructural determinants such as gender, age, sexual identity, geography, income and ethnicity influence engagement in HIV care. Participants Between January 2016 and September 2018, 644 BC residents who were at least 19 years old and diagnosed with HIV were enrolled in the study and completed a baseline survey. Participants will complete two additional follow-up surveys (18 months apart) about their HIV care experiences, with clinical follow-up ongoing. Findings to date Analyses on baseline data have found high levels of HIV care engagement and treatment success among SHAPE participants, with 95% of participants receiving antiretroviral therapy and 90% having achieved viral suppression. However, persistent disparities in HIV treatment outcomes related to age, injection drug use and housing stability have been identified and require further attention when delivering services to marginalised groups. Future plans Our research will examine how engagement in HIV care evolves over time, continuing to identify barriers and facilitators for promoting equitable access to treatment and care among people living with HIV. A qualitative research project, currently in the formative phase, will compliment quantitative analyses by taking a strengths-based approach to exploring experiences of engagement and re-engagement in HIV treatment among individuals who have experienced delayed treatment initiation or treatment interruptions.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The changing age and seasonal profile of pertussis in British Columbia, not Canada
    Galanis, E
    King, A
    Varughese, P
    JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (10): : 1537 - 1538
  • [22] AIDS TESTING INFORMATION PROGRAM PIONEERED IN BRITISH-COLUMBIA
    不详
    CANADIAN FAMILY PHYSICIAN, 1988, 34 : 1285 - 1287
  • [23] Drug costs for HIV/AIDS treatment in British Columbia.
    Anis, AH
    Hogg, RS
    Montaner, JSG
    Yip, B
    Wang, W
    OShaughnessy, MV
    Schechter, MT
    AIDS, 1996, 10 : P25 - P25
  • [24] Evaluation of photo radar program in British Columbia
    Chen, G
    Wilson, J
    Meckle, W
    Cooper, P
    ACCIDENT ANALYSIS AND PREVENTION, 2000, 32 (04): : 517 - 526
  • [25] EVALUATION OF THE BRITISH-COLUMBIA AIDS INFORMATION LINE
    PARSONS, DC
    BELL, MA
    GILCHRIST, LD
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1991, 82 (06): : 399 - 403
  • [26] Factors Associated with Disclosure of HIV Status Among a Cohort of Individuals on Antiretroviral Therapy in British Columbia, Canada
    Allen, A. J. Hirsch
    Forrest, Jamie I.
    Kanters, Steve
    O'Brien, Nadia
    Salters, Kate A.
    McCandless, Lawrence
    Montaner, Julio S. G.
    Hogg, Robert S.
    AIDS AND BEHAVIOR, 2014, 18 (06) : 1014 - 1026
  • [27] Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada
    MacDougall, Laura
    Smolina, Kate
    Otterstatter, Michael
    Zhao, Bin
    Chong, Mei
    Godfrey, David
    Mussavi-Rizi, Ali
    Sutherland, Jenny
    Kuo, Margot
    Kendall, Perry
    PLOS ONE, 2019, 14 (01):
  • [28] Factors Associated with Disclosure of HIV Status Among a Cohort of Individuals on Antiretroviral Therapy in British Columbia, Canada
    A. J. Hirsch Allen
    Jamie I. Forrest
    Steve Kanters
    Nadia O’Brien
    Kate A. Salters
    Lawrence McCandless
    Julio S. G. Montaner
    Robert S. Hogg
    AIDS and Behavior, 2014, 18 : 1014 - 1026
  • [29] The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, Canada
    Lima, Viviane D.
    Brumme, Zabrina L.
    Brumme, Chanson
    Sereda, Paul
    Krajden, Mel
    Wong, Jason
    Guillemi, Silvia A.
    Henry, Bonnie
    Hogg, Robert S.
    Barrios, Rolando
    Montaner, Julio S. G.
    CURRENT HIV/AIDS REPORTS, 2020, 17 (02) : 77 - 87
  • [30] The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, Canada
    Viviane D. Lima
    Zabrina L. Brumme
    Chanson Brumme
    Paul Sereda
    Mel Krajden
    Jason Wong
    Silvia A. Guillemi
    Bonnie Henry
    Robert S. Hogg
    Rolando Barrios
    Julio S. G. Montaner
    Current HIV/AIDS Reports, 2020, 17 : 77 - 87